Search Results

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Infusion Nurses Society Annual Meeting and Exhibition, to be held in Kansas City, Missouri from Saturday, May 18 to Monday, May 20, 2024.

Covalon Technologies Ltd., an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open.

Covalon Technologies Ltd. today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately.

Covalon Technologies Ltd. today announced the following management changes.

Covalon Technologies Ltd. today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.

Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders held March 6, 2024.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast.

Covalon Technologies Ltd. today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors (the “Board”) has appointed Amir Boloor, Chair of the Company’s Board, as Interim Chief Executive Officer (“CEO”), effective immediately following the departure of Brian Pedlar.